New Alzheimer’s Treatment on Horizon as Dementia Reversed for First Time in Dogs
SYDNEY, June 21 (Korea Bizwire) — With the once dominant amyloid hypothesis of Alzheimer’s disease suffering yet another crushing blow this week, the field is desperate for a ray of hope. Enter S2N, a new Australian biotech pioneering an all-new neurorestorative approach, aiming to rebuild and replace the lost brain cells in Alzheimer’s that underlies clinical symptoms. [...]